Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 397

Similar articles for PubMed (Select 18954848)

1.

Prior statin use is associated with improved outcomes in community-acquired pneumonia.

Chalmers JD, Singanayagam A, Murray MP, Hill AT.

Am J Med. 2008 Nov;121(11):1002-1007.e1. doi: 10.1016/j.amjmed.2008.06.030.

PMID:
18954848
2.

C-reactive protein is an independent predictor of severity in community-acquired pneumonia.

Chalmers JD, Singanayagam A, Hill AT.

Am J Med. 2008 Mar;121(3):219-25. doi: 10.1016/j.amjmed.2007.10.033.

PMID:
18328306
3.

Incidence and prognostic implications of acute kidney injury on admission in patients with community-acquired pneumonia.

Akram AR, Singanayagam A, Choudhury G, Mandal P, Chalmers JD, Hill AT.

Chest. 2010 Oct;138(4):825-32. doi: 10.1378/chest.09-3071. Epub 2010 Apr 30.

PMID:
20435657
4.

Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia.

Chalmers JD, Singanayagam A, Murray MP, Scally C, Fawzi A, Hill AT.

Thorax. 2009 Jul;64(7):592-7. doi: 10.1136/thx.2008.105080. Epub 2009 Jan 8.

PMID:
19131449
5.

Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients.

Thomsen RW, Riis A, Kornum JB, Christensen S, Johnsen SP, Sørensen HT.

Arch Intern Med. 2008 Oct 27;168(19):2081-7. doi: 10.1001/archinte.168.19.2081.

PMID:
18955636
6.

Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia.

Chalmers JD, Singanayagam A, Hill AT.

Thorax. 2008 Aug;63(8):698-702. doi: 10.1136/thx.2008.095562. Epub 2008 May 20.

PMID:
18492742
7.

Why mortality is increased in health-care-associated pneumonia: lessons from pneumococcal bacteremic pneumonia.

Rello J, Luján M, Gallego M, Vallés J, Belmonte Y, Fontanals D, Diaz E, Lisboa T; PROCORNEU Study Group.

Chest. 2010 May;137(5):1138-44. doi: 10.1378/chest.09-2175. Epub 2009 Dec 1.

PMID:
19952058
8.

Disease risk and mortality prediction in intensive care patients with pneumonia. Australian and New Zealand practice in intensive care (ANZPIC II).

Boots RJ, Lipman J, Bellomo R, Stephens D, Heller RF.

Anaesth Intensive Care. 2005 Feb;33(1):101-11.

PMID:
15957699
9.

Prior statin therapy is associated with a decreased rate of severe sepsis.

Almog Y, Shefer A, Novack V, Maimon N, Barski L, Eizinger M, Friger M, Zeller L, Danon A.

Circulation. 2004 Aug 17;110(7):880-5. Epub 2004 Aug 2.

10.

Beneficial effects of statin therapy on survival in hypertensive patients with acute myocardial infarction: data from the RICO survey.

Sicard P, Zeller M, Dentan G, Laurent Y, Touzery C, L'huillier I, Janin-Manificat L, Lorgis L, Beer JC, Makki H, Rochette L, Cottin Y; RICO survey working group.

Am J Hypertens. 2007 Nov;20(11):1133-9.

PMID:
17954357
11.

Preinjury statin use is associated with improved in-hospital survival in elderly trauma patients.

Efron DT, Sorock G, Haut ER, Chang D, Schneider E, Mackenzie E, Cornwell EE 3rd, Jurkovich GJ.

J Trauma. 2008 Jan;64(1):66-73; discussion 73-4. doi: 10.1097/TA.0b013e31815b842a.

PMID:
18188101
12.

Prognosis factors and outcome of community-acquired pneumonia needing mechanical ventilation.

Tejerina E, Frutos-Vivar F, Restrepo MI, Anzueto A, Palizas F, González M, Apezteguía C, Abroug F, Matamis D, Bugedo G, Esteban A; International Mechanical Ventilation Study Group.

J Crit Care. 2005 Sep;20(3):230-8.

PMID:
16253791
13.

Admission D-dimer can identify low-risk patients with community-acquired pneumonia.

Chalmers JD, Singanayagam A, Scally C, Hill AT.

Ann Emerg Med. 2009 May;53(5):633-8. doi: 10.1016/j.annemergmed.2008.12.022. Epub 2009 Feb 7.

PMID:
19201061
14.

Admission hypoglycaemia is associated with adverse outcome in community-acquired pneumonia.

Singanayagam A, Chalmers JD, Hill AT.

Eur Respir J. 2009 Oct;34(4):932-9. doi: 10.1183/09031936.00197008. Epub 2009 Jun 18.

15.

Statin therapy is associated with decreased mortality in patients with infection.

Donnino MW, Cocchi MN, Howell M, Clardy P, Talmor D, Cataldo L, Chase M, Al-Marshad A, Ngo L, Shapiro NI.

Acad Emerg Med. 2009 Mar;16(3):230-4. doi: 10.1111/j.1553-2712.2009.00350.x.

PMID:
19281494
16.

Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study.

Myles PR, Hubbard RB, McKeever TM, Pogson Z, Smith CJ, Gibson JE.

Pharmacoepidemiol Drug Saf. 2009 Apr;18(4):269-75. doi: 10.1002/pds.1715.

PMID:
19235776
17.

Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia.

Yandiola PP, Capelastegui A, Quintana J, Diez R, Gorordo I, Bilbao A, Zalacain R, Menendez R, Torres A.

Chest. 2009 Jun;135(6):1572-9. doi: 10.1378/chest.08-2179. Epub 2009 Jan 13.

PMID:
19141524
18.

Early effects of statins in patients with coronary artery disease and high C-reactive protein.

Muhlestein JB, Anderson JL, Horne BD, Carlquist JF, Bair TL, Bunch TJ, Pearson RR; Intermountain Heart Collaborative Study Group.

Am J Cardiol. 2004 Nov 1;94(9):1107-12.

PMID:
15518602
19.

Association between surfactant protein B + 1580 polymorphism and the risk of respiratory failure in adults with community-acquired pneumonia.

Quasney MW, Waterer GW, Dahmer MK, Kron GK, Zhang Q, Kessler LA, Wunderink RG.

Crit Care Med. 2004 May;32(5):1115-9.

PMID:
15190959
20.

The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia.

McAlister FA, Majumdar SR, Blitz S, Rowe BH, Romney J, Marrie TJ.

Diabetes Care. 2005 Apr;28(4):810-5.

PMID:
15793178
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk